Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More…
Industry, Sector and Symbol
Industry Prepackaged software
Sub-IndustryApplication Software
SectorComputer and Technology
Phone650-584-5000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.12 billion
Profitability
Miscellaneous
Employees13,245
Next Earnings Date12/4/2019 (Estimated)
OptionableOptionable
Synopsys (NASDAQ:SNPS) Frequently Asked Questions
What is Synopsys' stock symbol?
Synopsys trades on the NASDAQ under the ticker symbol "SNPS."
How will Synopsys' stock buyback program work?
Synopsys announced that its Board of Directors has initiated a stock repurchase plan on Thursday, April 5th 2018, which allows the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 4.1% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's board of directors believes its shares are undervalued.
How were Synopsys' earnings last quarter?
Synopsys, Inc. (NASDAQ:SNPS) issued its quarterly earnings data on Wednesday, August, 21st. The semiconductor company reported $0.65 earnings per share for the quarter, topping analysts' consensus estimates of $0.62 by $0.03. The semiconductor company earned $853 million during the quarter, compared to analysts' expectations of $831.03 million. Synopsys had a net margin of 18.74% and a return on equity of 16.88%. The business's quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.95 EPS. View Synopsys' Earnings History.
When is Synopsys' next earnings date?
What guidance has Synopsys issued on next quarter's earnings?
Synopsys updated its fourth quarter earnings guidance on Wednesday, August, 21st. The company provided earnings per share (EPS) guidance of $1.10-1.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.01. The company issued revenue guidance of $830-860 million, compared to the consensus revenue estimate of $838.45 million.
What price target have analysts set for SNPS?
10 brokers have issued twelve-month price targets for Synopsys' stock. Their predictions range from $98.00 to $160.00. On average, they expect Synopsys' stock price to reach $136.6667 in the next twelve months. This suggests that the stock has a possible downside of 1.7%. View Analyst Price Targets for Synopsys.
What is the consensus analysts' recommendation for Synopsys?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Synopsys in the last year. There are currently 2 hold ratings, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Synopsys.
Has Synopsys been receiving favorable news coverage?
News coverage about SNPS stock has trended positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Synopsys earned a news sentiment score of 2.5 on InfoTrie's scale. They also gave news headlines about the semiconductor company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the stock's share price in the near term. View News Stories for Synopsys.
Are investors shorting Synopsys?
Synopsys saw a decline in short interest in the month of July. As of July 31st, there was short interest totalling 1,760,300 shares, a decline of 11.3% from the June 30th total of 1,985,500 shares. Based on an average trading volume of 1,170,000 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.2% of the shares of the stock are short sold. View Synopsys' Current Options Chain.
Who are some of Synopsys' key competitors?
Some companies that are related to Synopsys include Intuit (INTU), VMware (VMW), Uber Technologies (UBER), ServiceNow (NOW), Shopify (SHOP), Dassault Systemes (DASTY), Activision Blizzard (ATVI), Autodesk (ADSK), Square (SQ), Electronic Arts (EA), Veeva Systems (VEEV), Crowdstrike (CRWD), Cadence Design Systems (CDNS), Splunk (SPLK) and CA (CA).
What other stocks do shareholders of Synopsys own?
Who are Synopsys' key executives?
Synopsys' management team includes the folowing people:
- Dr. Aart J. de Geus, Co-Founder, Chairman & Co-CEO (Age 65)
- Dr. Chi-Foon Chan, Co-CEO, Pres & Director (Age 70)
- Mr. Trac Pham, Chief Financial Officer (Age 50)
- Mr. John F. Runkel Jr., Gen. Counsel & Corp. Sec. (Age 63)
- Mr. Joseph W. Logan, Sales & Corp. Marketing Officer (Age 59)
Who are Synopsys' major shareholders?
Synopsys' stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.05%), BlackRock Inc. (8.60%), Price T Rowe Associates Inc. MD (6.72%), JPMorgan Chase & Co. (4.16%), Parnassus Investments CA (3.48%) and Invesco Ltd. (2.34%). Company insiders that own Synopsys stock include Chi-Foon Chan, Chrysostomos L Nikias, Geus Aart De, John F Runkel Jr, John Schwarz, Joseph W Logan, Roy Vallee, Steven Walske, Sudhindra Kankanwadi and Trac Pham. View Institutional Ownership Trends for Synopsys.
Which institutional investors are selling Synopsys stock?
SNPS stock was sold by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Egerton Capital UK LLP, Prudential Financial Inc., Pictet Asset Management Ltd., Price T Rowe Associates Inc. MD, D. E. Shaw & Co. Inc., Victory Capital Management Inc. and Amundi Pioneer Asset Management Inc.. Company insiders that have sold Synopsys company stock in the last year include Chi-Foon Chan, Chrysostomos L Nikias, Geus Aart De, John F Runkel Jr, John Schwarz, Joseph W Logan, Roy Vallee, Steven Walske, Sudhindra Kankanwadi and Trac Pham. View Insider Buying and Selling for Synopsys.
Which institutional investors are buying Synopsys stock?
SNPS stock was bought by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, JPMorgan Chase & Co., Invesco Ltd., BlackRock Inc., Marshall Wace North America L.P., WINTON GROUP Ltd, UBS Group AG and PointState Capital LP. View Insider Buying and Selling for Synopsys.
How do I buy shares of Synopsys?
Shares of SNPS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Synopsys' stock price today?
One share of SNPS stock can currently be purchased for approximately $139.00.
How big of a company is Synopsys?
Synopsys has a market capitalization of $20.84 billion and generates $3.12 billion in revenue each year. The semiconductor company earns $432.51 million in net income (profit) each year or $2.82 on an earnings per share basis. Synopsys employs 13,245 workers across the globe.View Additional Information About Synopsys.
What is Synopsys' official website?
How can I contact Synopsys?
Synopsys' mailing address is 690 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The semiconductor company can be reached via phone at 650-584-5000 or via email at [email protected]
MarketBeat Community Rating for Synopsys (NASDAQ SNPS)
MarketBeat's community ratings are surveys of what our community members think about Synopsys and other stocks. Vote "Outperform" if you believe SNPS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNPS will underperform the S&P 500 over the long term. You may vote once every thirty days.
